The CAMP (Christie-Atkins-Munch-Petersen) test 
Infections in adults and neonates caused by group B streptococci are associated with high morbidity and mortality. Gram-positive cocci isolated from normally sterile specimens from such patients require prompt and accurate identification. Presumptive tests for identification of group B streptococci are often used by clinical laboratories because of their relative simplicity and cost effectiveness compared with serological identification (e.g., the Lancefield precipitin, latex agglutination, or coagglutination tests). Of the several presumptive tests, the CAMP (Christie-AtkinsMunch-Petersen) test, originally described by Christie et al. (1) , is often used because it requires minimal reagents, employs a simple methodology, is inexpensive, and rarely gives false-positive reactions with other streptococcal groups.
In an effort to make the standard CAMP test more rapid or more simple or both, several modifications have been proposed (6, 10, 11 
